• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • News & Insights
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE News & Insights (Formerly CBE Week)
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE News & Insights (Formerly CBE Week)
    • CBE Policy and Legal
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • PR Newswire
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / News & Insights / Compliance and Regulations / DripDripDrip – What is AG Jeff Sessions Up To Now?

DripDripDrip – What is AG Jeff Sessions Up To Now?

December 20, 2017 by David Hodes Leave a Comment

What is U.S. Attorney General Jeff Sessions working on today that affects the cannabis industry, and who is he working on it with? If the most recent meeting held just two weeks ago is any indication, he’s digging in deeper in his quest to stop legalization, and calling in bigger policy and researcher guns to back him up.

In addition to ducking the jabs from the President Trump who is reportedly still dogging him for his recusal stunt, Sessions attended a meeting December 8 put together by the former attorney general under Ronald Reagan, Edwin Meese, along with the Heritage Foundation, coming together at the Department of Justice with a group of anti-marijuana folks who clearly want to provide the attorney general some go-get-’em firepower.

One of the attendees at this meeting was Dr. Bertha Madras. I attended a meeting at the Brookings Institution on November 3 featuring Madras as a panelist. She is a psychobiology professor at Harvard Medical School and a member of the President’s Commission on Combatting Drug Addiction and the Opioid Crisis. She discussed the recommendations from the committee. She also claimed at that meeting that data about marijuana overdoses was being withheld, affecting the work of the commission in presenting all the facts about the scourge of marijuana addiction. “People who use marijuana for pain medications also have higher rates of opioid use and opioid use disorder,” she said at the Brookings Institute panel. “The data for long-term outcomes – the suppression of evidence that marijuana is addictive – parallels what is happening in the opioid crisis.”

Others in the room for the meeting at the DOJ that was closed to the press included Meese, now the Ronald Reagan Distinguished Fellow Emeritus at Heritage. Also present were Robert DuPont, the first director of the National Institute on Drug Abuse; David Evans, executive director of the Drug Free Schools Coalition; and Dr. Hoover Adger, professor of pediatrics at the Johns Hopkins University School of Medicine and director of adolescent medicine at Johns Hopkins Hospital.

To say nothing good could come from this stew of anti-marijuana power players is a grim understatement.

In a letter to the New York Times in April, 2016, DuPont, now the president of the Institute for Behavior and Health, wrote: “We are at a crossroads. Legalizing marijuana will have lasting negative effects on future generations. The currently legal drugs, alcohol and tobacco, are two of the leading causes of preventable illness and death in the country. Establishing marijuana as a third legal drug will increase the national drug abuse problem, including expanding the opioid epidemic.”

In a 2012 U.S. News op-ed, Evans, who was also a leading member of the National Student Drug-Testing Committee, wrote “‘The ‘war’ on drugs has improved the nation’s health and is a good social policy.”

Dr. Adger is one of a dozen doctors on the staff of Smart Approaches to Marijuana (SAM), an organization that “envisions a society where marijuana policies are aligned with the scientific understanding of marijuana’s harms, and the commercialization and normalization of marijuana are no more.”

Though no report from the meeting was available, nor has any surfaced since the meeting, freezing and zooming into a brief CSPAN video from the beginning of the meeting when Sessions arrived showed him holding a printed page listing the agenda that included discussions of marijuana not being a substitute for opioids, drugged driving and other anti-marijuana points.

“Well, thank you for coming,” Sessions said as he sat and addressed the group and set the tone. “I appreciate the opportunity to hear your analysis on marijuana and some of the related issues. It’s a big issue for America, and for the country. I am of the general view that this is not a healthy substance. I think that is pretty clear. And then as a policy response, we and the federal government need to be prepared and do so appropriately and with good sense. I do believe and am afraid that the public is not properly educated on some of the issues related to marijuana. That is what all of us working here today would want to do is to allow better policy to be enacted.” Then the CSPAN camera guy was hustled out of the room.

Speculation is that the ensuing discussion centered around what to do about the Cole memo, which Sessions appears to have in his crosshairs (“In fact, we’re working on that very hard right now,” he said at a press conference recorded by CSPAN in late November.) There may also have been discussion about action on the Rohrabacher-Blumenauer amendment.

Maybe arch-conservative Meese had an angle to present regarding decriminalization efforts, since he did demonstrate an understanding of issues related to wrongful incarceration in the introduction he wrote to a book published years ago by two Heritage Foundation veterans, Paul Rosenzweig and Brian Walsh, “One Nation Under Arrest.” But that’s just wishful thinking.

Meese and Sessions seem to be on the same page when it comes to being against marijuana legalization and following the letter of the law. Meese has called Session a good friend – they have known each other for 35-plus years. Sessions was one of Ronald Reagan’s first appointees as U.S. attorney for the southern district of Alabama during the “Just Say No” days.

And this was not the first time that Meese invited Sessions to talk about his work as attorney general and address drug policy.

At the Heritage Fall Legal Strategy forum in October 2017 moderated by Meese, Sessions said that the country should adopt a “just say no” mentality about drugs, echoing voices from the past. Then he talked about marijuana. “I do think that this whole country needs to not be so lackadaisical about drugs,” he said. “You talk to police chiefs and they consistently say much of the drug addiction starts with marijuana, and that it is not a harmless drug. So the challenge for law enforcement is really tough and we are going to be working on that.”

Contextual Links

Filed Under: Compliance and Regulations, Policy & Legal Tagged With: Cole Memo, David Evans, Dr. Bertha Madras, Dr. Hoover Adger, executive director of the Drug Free Schools Coalition, Heritage Foundation, President Trump, President’s Commission on Combatting Drug Addiction and the Opioid Crisis, professor of pediatrics at the Johns Hopkins University School of Medicine, Robert DuPont, Rohrabacher- Blumenauer amendment, the first director of the National Institute on Drug Abuse, U.S. Attorney General Jeff Sessions

About David Hodes

David Hodes is based in the greater Washington DC metropolitan area. He is the former editor of seven different business magazines, and has contributed feature articles to several business/lifestyle publications and national cannabis magazines. Hodes is also a former field producer for CBS News, NBC, NFL Network, ESPN and other media outlets; worked as a news promotions producer for two network affiliates; and was the morning news editor for a third network affiliate.

He is member of the National Press Club, and deputy booking agent for the National Press Club Headliners Committee.

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Brand & Show Marketing Director - Marijuana Business Daily - Lakewood, CO
  • GC/MS Scientist - VRS Recruitment - , OR
  • Brand & Show Marketing Director - Marijuana Business Daily - Lakewood, CO

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·